176 related articles for article (PubMed ID: 16258272)
1. What is the role of tubular epithelial cell apoptosis in polycystic kidney disease (PKD)?
Edelstein CL
Cell Cycle; 2005 Nov; 4(11):1550-4. PubMed ID: 16258272
[TBL] [Abstract][Full Text] [Related]
2. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
Pey R; Bach J; Schieren G; Gretz N; Hafner M
In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and autophagy in polycystic kidney disease (PKD).
Nowak KL; Edelstein CL
Cell Signal; 2020 Apr; 68():109518. PubMed ID: 31881325
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL
Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852
[TBL] [Abstract][Full Text] [Related]
5. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
[TBL] [Abstract][Full Text] [Related]
6. ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
Hocher B; Kalk P; Slowinski T; Godes M; Mach A; Herzfeld S; Wiesner D; Arck PC; Neumayer HH; Nafz B
J Am Soc Nephrol; 2003 Feb; 14(2):367-76. PubMed ID: 12538737
[TBL] [Abstract][Full Text] [Related]
7. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease.
Ramasubbu K; Gretz N; Bachmann S
J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276
[TBL] [Abstract][Full Text] [Related]
8. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
Liu C; Zhang Y; Yuan L; Fu L; Mei C
Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
[TBL] [Abstract][Full Text] [Related]
10. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
[TBL] [Abstract][Full Text] [Related]
11. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels.
Park JY; Schutzer WE; Lindsley JN; Bagby SP; Oyama TT; Anderson S; Weiss RH
BMC Nephrol; 2007 Aug; 8():12. PubMed ID: 17714589
[TBL] [Abstract][Full Text] [Related]
12. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
[TBL] [Abstract][Full Text] [Related]
13. Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression.
Trudel M; Barisoni L; Lanoix J; D'Agati V
Am J Pathol; 1998 Jan; 152(1):219-29. PubMed ID: 9422539
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.
Idowu J; Home T; Patel N; Magenheimer B; Tran PV; Maser RL; Ward CJ; Calvet JP; Wallace DP; Sharma M
Sci Rep; 2018 Feb; 8(1):3340. PubMed ID: 29463793
[TBL] [Abstract][Full Text] [Related]
15. The consequences of increased 4E-BP1 in polycystic kidney disease.
Holditch SJ; Brown CN; Atwood DJ; Pokhrel D; Brown SE; Lombardi AM; Nguyen KN; Hill RC; Lanaspa M; Hopp K; Weiser-Evans MCM; Edelstein CL
Hum Mol Genet; 2019 Dec; 28(24):4132-4147. PubMed ID: 31646342
[TBL] [Abstract][Full Text] [Related]
16. Activation of Notch3 in Renal Tubular Cells Leads to Progressive Cystic Kidney Disease.
Djudjaj S; Kavvadas P; Prakoura N; Bülow RD; Migeon T; Placier S; Chadjichristos CE; Boor P; Chatziantoniou C
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055068
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
18. ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease.
Beck Gooz M; Maldonado EN; Dang Y; Amria MY; Higashiyama S; Abboud HE; Lemasters JJ; Bell PD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F551-9. PubMed ID: 24899059
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of polycystic kidney disease.
Carone FA; Bacallao R; Kanwar YS
Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
[TBL] [Abstract][Full Text] [Related]
20. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
